Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

23. Juli 2019 04:30 ET | Quelle: Global Market Insights, Inc

Kaempferol Market value to hit $6.5 billion by 2025: Global Market Insights, Inc.

Selbyville, Delaware, July 23, 2019 (GLOBE NEWSWIRE) -- U.S. 98% kaempferol market demand from pharmaceutical applications may register gains close to 4% by the foreseeable timeframe. According to...
23. Juli 2019 01:51 ET | Quelle: Curetis

Curetis Files for U.S. FDA 510(k) Clearance of Unyvero LRT for BAL Specimens

- Final LRT BAL panel demonstrates overall weighted average sensitivity of up to 94.7% and overall weighted average specificity of up to 98.4% - Unyvero provides results after approximately five...
22. Juli 2019 12:50 ET | Quelle: Research and Markets

Outlook on the Global Novel Immuno-Oncology Biomarker Testing to 2030 - Increasing Focus on Precision Medicine & Rise in Number of Biomarker-based Clinical Trials Presents Opportunities

Dublin, July 22, 2019 (GLOBE NEWSWIRE) -- The "Novel Immuno-Oncology Biomarker Testing Market, 2019-2030" report has been added to ResearchAndMarkets.com's offering. This report...
22. Juli 2019 11:24 ET | Quelle: Reports and Data

Nanoemulsions Market To Reach USD 16.18 Billion By 2026 | Reports And Data

New York, July 22, 2019 (GLOBE NEWSWIRE) -- The increase in awareness regarding chronic diseases and availability of nanoemulsion treatments is driving the growth of the market. The global...
22. Juli 2019 08:30 ET | Quelle: GTEC Holdings Ltd.

GTEC Enters into Agreement to Acquire Facility in Kelowna BC

Kelowna, BC, July 22, 2019 (GLOBE NEWSWIRE) -- GTEC Holdings Ltd. (TSX-V:GTEC) (OTCQB:GGTTF) (FRA:1BUP) (“GTEC” or the “Company”) is pleased to announce that GTEC and Canopy Growth Corporation...
22. Juli 2019 07:00 ET | Quelle: Cyclacel

Cyclacel Pharmaceuticals Announces First Patient Treated in a Phase 1/2 Study of Sapacitabine and Venetoclax in Relapsed or Refractory AML or MDS Patients

BERKELEY HEIGHTS, N.J., July 22, 2019 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC, Nasdaq:CYCCP) ("Cyclacel" or the "Company"), a biopharmaceutical company developing innovative...
22. Juli 2019 06:55 ET | Quelle: Interpace Diagnostics Group, Inc.

Interpace Announces New Agreement with SelectHealth

Expected to Benefit More than 850,000 Members PARSIPPANY, NJ, July 22, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) announced today that it has reached an agreement...
22. Juli 2019 06:00 ET | Quelle: Adynxx, Inc.

Adynxx Adds Gregory J. Flesher to Board of Directors, Completes Up-listing to OTCQB Market

SAN FRANCISCO, July 22, 2019 (GLOBE NEWSWIRE) -- Adynxx, Inc. (OTCQB: ADYX), a clinical-stage biopharmaceutical company focused on the development of transcription factor decoy technology and...
22. Juli 2019 06:00 ET | Quelle: Neal Davis Law Firm

New Report Shows Where Exonerations Happen in the US (State-by-State)

HOUSTON, July 22, 2019 (GLOBE NEWSWIRE) -- Texas currently leads the nation in exonerations, despite having some of the toughest laws on crime. This is one of the many interesting findings in a new...
22. Juli 2019 05:10 ET | Quelle: Research and Markets

Global Regenerative Medicine Markets, 2010-2018 - Market Driven by Kymriah and Yescarta

Dublin, July 22, 2019 (GLOBE NEWSWIRE) -- The "Global Market for Regenerative Medicine (RM), 2019" report has been added to ResearchAndMarkets.com's offering. The Regenerative...

Vorherige Seite

Nächste Seite